The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 28, No. 3, pp. 392-395.
© 1994 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, E.
Right arrow Articles by Grillo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, E.
Right arrow Articles by Grillo, J.


Research Articles

Over-the-counter histamine2-blocker therapy

ER Gonzalez and JA Grillo

In determining whether a prescription medication should be granted OTC status, the risks and benefits of treatment with the medication must be weighed. Ultimately, the decision must be made with some degree of uncertainty. Pharmacists must take advantage of this uncertainty to demonstrate their professional expertise and value to society. The Rx-to-OTC switch for H2-blockers may benefit many, although not all, patients with acid peptic complaints, and it offers pharmacists an opportunity to demonstrate their willingness and ability to assist in the use of cost-effective OTC drug therapy.





homecopy help contact us subscription past issues search current issue
Copyright © 1994 by Harvey Whitney Books Company.